40
ORF Biologics, Inc. raises $1.7M under Reg D
Company raise · Raising · Offering $2.5M · Sold $1.7M · TIFFIN, IA · filed 2026-07-31
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Steven Michalicek | Director |
| Jay Kamath | Executive Officer, Director |
| Sara Ternes | Executive Officer, Director |
| Stephen Hanson | Executive Officer, Director |
| Anant Kamath | Executive Officer, Director |
Signed by Anant Kamath, CEO.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.